The effect of covalently immobilized rhIL-1ra-ELP fusion protein on the inflammatory profile of LPS-stimulated human monocytes

Biomaterials

Volumn 28, Issue 23, 2007, Pages 3369-3377

  Kim, Dong Hwan ^a   Smith, Jason T ^a   Chilkoti, Ashutosh ^a   Reichert, William M ^a  

^a Duke University   (United States)

Author keywords

Cytokines; IL 1ra; Inflammation; Monocytes; Wound healing

Indexed keywords

CYTOKINES; IL-1RA; INFLAMMATION; MONOCYTES; WOUND HEALING;

BIOMATERIALS; CELL IMMOBILIZATION; CELLS; ESCHERICHIA COLI; MEDICAL PROBLEMS; PEPTIDES;

PROTEINS;

BIOMATERIAL; CYTOKINE; HYBRID PROTEIN; LIPOPOLYSACCHARIDE; RECOMBINANT INTERLEUKIN 1 RECEPTOR ANTAGONIST ELASTIN LIKE PEPTIDE FUSION PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; MONOCYTE; PRIORITY JOURNAL;

CELLS, CULTURED; CYTOKINES; ESCHERICHIA COLI; HUMANS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LIPOPOLYSACCHARIDES; MODELS, IMMUNOLOGICAL; MONOCYTES; RECEPTORS, INTERLEUKIN-1; RECOMBINANT FUSION PROTEINS;

ESCHERICHIA COLI;

EID: 34248200349     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2007.04.010     Document Type: Article

References (46)

1. Hirano Y., and Mooney D.J. Peptide and protein presenting materials for tissue engineering. Adv Mater 16 1 (2004) 17-25
2. Ratner B.D., and Bryant S.J. Biomaterials: where we have been and where we are going. Annu Rev Biomed Eng 6 (2004) 41-75
3. Alsberg E., Anderson K.W., Albeiruti A., Rowley J.A., and Mooney D.J. Engineering growing tissues. P Natl Acad Sci USA 99 19 (2002) 12025-12030
4. Hubbell J.A. Bioactive biomaterials. Curr Opin Biotech 10 2 (1999) 123-129
5. Prime K.L., and Whitesides G.M. Self-assembled organic monolayers-model systems for studying adsorption of proteins at surfaces. Science 252 5009 (1991) 1164-1167
6. Anderson J.M. Biological responses to materials. Ann Rev Mater Res 31 (2001) 81-110
7. Thomson A.W., and Lotze M.T. The cytokine handbook (2003), Academic Press, San Diego
8. Brodbeck W.G., Voskerician G., Ziats N.P., Nakayama Y., Matsuda T., and Anderson J.M. In vivo leukocyte cytokine mRNA responses to biomaterials are dependent on surface chemistry. J Biomed Mater Res A 64A 2 (2003) 320-329
9. Dinarello C.A. The Interleukin-1 family-10 years of discovery. FASEB J 8 15 (1994) 1314-1325
10. Bresnihan B., Alvaro-Gracia J.M., Cobby M., Doherty M., Domljan Z., Emery P., et al. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum 41 12 (1998) 2196-2204
11. Cominelli F., and Pizarro T.T. Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease. Aliment Pharmacol Ther 10 Suppl. 2 (1996) 49-53 (discussion 54)
12. Broide D.H., Lotz M., Cuomo A.J., Coburn D.A., Federman E.C., and Wasserman S.I. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol 89 5 (1992) 958-967
13. Shirakawa F., Tanaka Y., Oda S., Eto S., and Yamashita U. Autocrine stimulation of interleukin 1 alpha in the growth of adult human T-cell leukemia cells. Cancer Res 49 5 (1989) 1143-1147
14. Allan S.M., Tyrrell P.J., and Rothwell N.J. Interleukin-1 and neuronal injury. Nat Rev Immunol 5 8 (2005) 629-640
15. Economides A.N., Carpenter L.R., Rudge J.S., Wong V., Koehler-Stec E.M., Hartnett C., et al. Cytokine traps: multi-component, high-affinity blockers of cytokine action. Nat Med 9 1 (2003) 47-52
16. Preas H.L., Reda D., Tropea M., Vandivier R.W., Banks S.M., Agosti J.M., et al. Effects of recombinant soluble type I interleukin-1 receptor on human inflammatory responses to endotoxin. Blood 88 7 (1996) 2465-2472
17. De Crescenzo G., Pham P.L., Durocher Y., and O'Connor-McCourt M.D. Transforming growth factor-beta (TGF-beta) binding to the extracellular domain of the type II TGF-beta receptor: receptor capture on a biosensor surface using a new coiled-coil capture system demonstrates that avidity contributes significantly to high affinity binding. J Mol Biol 328 5 (2003) 1173-1183
18. Piehler J., and Schreiber G. Fast transient cytokine-receptor interactions monitored in real time by reflectometric interference spectroscopy. Anal Biochem 289 2 (2001) 173-186
19. Seipelt I., Hoffmann S.H., Schmidt J., Engels J.W., and Beckers T. Overexpression, purification, and use of a soluble human interleukin-4 receptor alpha-chain/Ig gamma 1 fusion protein for ligand binding studies-characterization of ligand binding to soluble IL-4 receptor alpha-chain by surface plasmon resonance measurements and by microtiter-plate-based ELISA with biotinylated IL-4. Biochem Biophys Res Commun 239 2 (1997) 534-542
20. Wu Z.N., Johnson K.W., Choi Y., and Ciardelli T.L. Ligand-binding analysis of soluble interleukin-2 receptor complexes by surface-plasmon resonance. J Biol Chem 270 27 (1995) 16045-16051
21. Webb D.J., Crookston K.P., Hall S.W., and Gonias S.L. Binding of transforming growth factor-beta-1 to immobilized human alpha-2-macroglobulin. Arch Biochem Biophys 292 2 (1992) 487-492
22. Fischer U., Hempel U., Becker D., Bierbaum S., Scharnweber D., Worch H., et al. Transforming growth factor beta1 immobilized adsorptively on Ti6Al4V and collagen type I coated Ti6Al4V maintains its biological activity. Biomaterials 24 15 (2003) 2631-2641
23. Ito Y., Hasuda H., Yamauchi T., Komatsu N., and Ikebuchi K. Immobilization of erythropoietin to culture erythropoietin-dependent human leukemia cell line. Biomaterials 25 12 (2004) 2293-2298
24. Mann B.K., Schmedlen R.H., and West J.L. Tethered-TGF-beta increases extracellular matrix production of vascular smooth muscle cells. Biomaterials 22 5 (2001) 439-444
25. Merrett K., Griffith C.M., Deslandes Y., Pleizier G., Dube M.A., and Sheardown H. Interactions of corneal cells with transforming growth factor beta 2-modified poly dimethyl siloxane surfaces. J Biomed Mater Res A 67 3 (2003) 981-993
26. Meyer D.E., and Chilkoti A. Purification of recombinant proteins by fusion with thermally-responsive polypeptides. Nat Biotech 17 11 (1999) 1112-1115
27. Chow D.C., Dreher M.R., Trabbic-Carlson K., and Chilkoti A. Ultra-high expression of a thermally responsive recombinant fusion protein in E. coli. Biotechnol Progr 22 3 (2006) 638-646
28. Vandenabeele P., Declercq W., Libert C., and Fiers W. Development of a simple, sensitive and specific bioassay for interleukin-1 based on the proliferation of Rpmi 1788 cells-comparison with other bioassays for Il-1. J Immun Method 135 1-2 (1990) 25-32
29. Vandenabeele P., Jayaram B., Devos R., Shaw A., and Fiers W. Interleukin-1-alpha acts as an autocrine growth-factor for Rpmi-1788, an Epstein-Barr virus-transformed human B-cell line. Eur J Immun 18 7 (1988) 1027-1031
30. Smith J.T., Viglianti B.L., and Reichert W.M. Spreading diagrams for the optimization of quill pin printed microarray density. Langmuir 18 16 (2002) 6289-6293
31. Hyun J., Lee W.K., Nath N., Chilkoti A., and Zauscher S. Capture and release of proteins on the nanoscale by stimuli-responsive elastin-like polypeptide "switches". J Am Chem Soc 126 23 (2004) 7330-7335
32. Stenberg E., Persson B., Roos H., and Urbaniczky C. Quantitative-determination of surface concentration of protein with surface-plasmon resonance using radiolabeled proteins. J Colloid Interface Sci 143 2 (1991) 513-526
33. Smith J.T., Tomfohr J.K., Wells M.C., Beebe T.P., Kepler T.B., and Reichert W.M. Measurement of cell migration on surface-bound fibronectin gradients. Langmuir 20 19 (2004) 8279-8286
34. Dinarello C.A., Ikejima T., Warner S.J.C., Orencole S.F., Lonnemann G., Cannon J.G., et al. Interleukin-1 induces interleukin-1. 1. Induction of circulating interleukin-1 in rabbits in vivo and in human mononuclear-cells in vitro. J Immunol 139 6 (1987) 1902-1910
35. Ikejima T., Okusawa S., Ghezzi P., Vandermeer J.W.M., and Dinarello C.A. Interleukin-1 induces tumor-necrosis-factor (TNF) in human peripheral-blood mononuclear-cells in vitro and a circulating TNF-like activity in rabbits. J Infect Dis 162 1 (1990) 215-223
36. Content J., Dewit L., Poupart P., Opdenakker G., Vandamme J., and Billiau A. Induction of a 26-kDa-protein messenger-RNA in human-cells treated with an interleukin-1-related, leukocyte-derived factor. Eur J Biochem 152 2 (1985) 253-257
37. Matsushima K., Morishita K., Yoshimura T., Lavu S., Kobayashi Y., Lew W., et al. Molecular-cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF messenger-RNA by interleukin-1 and tumor necrosis factor. J Exp Med 167 6 (1988) 1883-1893
38. Dinarello C.A., Cannon J.G., Wolff S.M., Bernheim H.A., Beutler B., Cerami A., et al. Tumor-necrosis-factor (Cachectin) is an endogenous pyrogen and induces production of interleukin-1. J Exp Med 163 6 (1986) 1433-1450
39. Bresnihan B., and Cunnane G. Interleukin-1 receptor antagonist. Rheum Dis Clin N Am 24 3 (1998) 615
40. Furst D.E., Breedveld F.C., Kalden J.R., Smolen J.S., Burmester G.R., Bijlsma J.W., et al. Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004. Ann Rheum Dis 63 Suppl 2 (2004) ii2-ii12
41. Braddock M., and Quinn A. Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention. Nat Rev Drug Discov 3 4 (2004) 330-339
42. Krakauer T., and Oppenheim J.J. Interleukin-1 production by a human acute monocytic leukemia-cell line. Cell Immunol 80 2 (1983) 223-229
43. Fenton M.J., Clark B.D., Collins K.L., Webb A.C., Rich A., and Auron P.E. Transcriptional regulation of the human prointerleukin-1-beta gene. J Immunol 138 11 (1987) 3972-3979
44. Marsh C.B., Moore S.A., Pope H.A., and Wewers M.D. IL-1ra suppresses endotoxin-induced IL-1-beta and TNF-alpha release from mononuclear phagocytes. Am J Physiol 267 1 (1994) L39-L45
45. Granowitz E.V., Vannier E., Poutsiaka D.D., and Dinarello C.A. Effect of interleukin-1 (Il-1) blockade on cytokine synthesis. 2. Il-1 receptor antagonist inhibits lipopolysaccharide-induced cytokine synthesis by human monocytes. Blood 79 9 (1992) 2364-2369
46. Arend W.P., Welgus H.G., Thompson R.C., and Eisenberg S.P. Biological properties of recombinant human monocyte-derived interleukin-1 receptor antagonist. J Clin Invest 85 5 (1990) 1694-1697